ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for ...
Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage biopharmaceutical company developing combination therapies for high-impact indications, today reported that it holds approximately $75 million ...
"This is changing the way we practice prostate cancer." White House chief of staff Susie Wiles has breast cancer. She'll join ...
ARV-102 reduced endolysosomal and neuroinflammatory biomarkers implicated in Parkinson’s disease and progressive supranuclear palsy – – ARV-102 was well tolerated across ...
Phase 2 Study Demonstrated 73% clinical Clearance in the 200-µg Arm suggests that ~3 out of 4 treated lesions may allow patients to avoid immediate surgical intervention.
In the rapidly evolving field of health and disease, the microbiota-gut-brain axis has emerged as a crucial element in understanding the complexities of inflammatory bowel disease ...
SGLT2 Inhibitors: Electrolyte, Water Balance, and Stone Prevention Benefits Beyond Metabolic Effects
Sodium-glucose cotransporter-2 (SGLT2) inhibitors have revolutionized the therapeutic landscape of cardiometabolic and renal diseases. Originally developed to lower blood glucose in type 2 diabetes by ...
HHS Secretary Robert F. Kennedy Jr. appointed Michelle Branham as chair of the federal Advisory Council on Alzheimer’s Research, Care, and Services.
Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...
Two international studies, a clinical trial led by the University of Oxford and University of Utrecht, and a qualitative ...
Southwest Science offers reliable personal laboratory centrifuge, centrifuge machine PRP, and medical centrifuge ...
A new analysis represents the largest effort yet to systematically parse all the data from high-quality clinical trials on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results